anti-CXCL16 antibody product blog
Tags: Antibody; Monoclonal Antibody; CXCL16; anti-CXCL16 antibody;
The CXCL16 cxcl16 (Catalog #MBS2541885) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The CXCL16 Monoclonal Antibody reacts with Human, Mouse and may cross-react with other species as described in the data sheet. MyBioSource\'s CXCL16 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), ELISA (EIA).WB: 1:200-1:1000. Researchers should empirically determine the suitability of the CXCL16 cxcl16 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The CXCL16 cxcl16 product has the following accession number(s) (GI #154816178) (NCBI Accession #NP_001094282.1) (Uniprot Accession #Q9H2A7). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the CXCL16 Monoclonal Antibody with the following immunoassay(s):
Western Blot (WB) (Western Blot analysis of SH-SY5Y cells using CXCL16 Monoclonal Antibody at dilution of 1:300)
CXCL16 is a recently discovered cytokine belonging to the CXC chemokine family, which is synthesised in plasmacytoid dendritic cell as a transmembrane molecule. It exists in a transmembrane and soluble form. The transmembrane form of CXCL16 functions as an adhesion molecule for CXCR6-expressing cells, whereas the soluble form of CXCL16 mediates infiltration of circulating cells into sites of injury. CXCL16, has been proposed as an important pathogenic mediator in inflammatory diseases, including rheumatoid arthritis, glomerulonephritis, or prostate cancer. CXCL16 has been implicated in some forms of renal disease such as lupus nephritis and antiglomerular basement membrane nephritis. CXCL16 also plays a pivotal role in the pathogenesis of angiotensin II-induced renal injury and fibrosis through regulation of macrophage and T cell infiltration and bone marrow-derived fibroblast accumulation.
Immunogen: Fusion protein of CXCL16. Buffer: PBS with 0.1% sodium azide, 50% glycerol, PH7.3
Conjugation: Unconjugated. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CXCL16 are readily searchable from our website. Different antibodies against the same target such as CXCL16 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Atherosclerosis, Carcinoma, Cardiovascular Diseases, Disease Models, Animal, Heart Diseases, Inflammation, Kidney Diseases, Liver Diseases, Necrosis, Nervous System Diseases are some of the diseases may be linked to CXCL16 Monoclonal Antibody.